Unparalleled Air Purity
for Healthcare

24×7 kill/remediation of all airborne bacterial, fungal and viral pathogens

0 M
HAIs Annually in the US
$ 0 B
Cost to US Healthcare System
0 %
of from Airborne Pathogens

LifeAire’s patented in-duct systems removes these pathogens and contaminants from your healthcare facility. As published recently in the peer-reviewed journal Surgery.

0 %
Reduction in LOS
0 %
Reduction in Costs
0 -Log
Kill of COVID-19
0
Patient Study

Used by the world’s leading healthcare organizations.

Our system has been installed to protect patient rooms specific to an ICU Medical Surgical floor. The data from 8,255 patients over a one year time period has revealed a reduction in HAIs and readmission rates, a statistically significant decrease in length of stay, improved discharge metrics and overall savings to the hospital. The data has been published in the journal, SurgerySimilarly, the System has been installed to protect the residents on a single floor in a leading senior living facility. The first 9 months of data have demonstrated a statistically significant reduction (39.7%) in HAIs over the control floor. This data is also being prepared for publication in a leading LTC journal. Want to see the results? We would welcome the opportunity to share this critical data with you and your colleagues. Please use the following form to request a copy.

    Designed to protect the most demanding, sensitive clinical healthcare environments in the world

    The LifeAire System was initially designed to protect the environment of the human embryo in the In Vitro Fertilization laboratory (one of the most sensitive cells to culture in vitro).

    This meant that it was critical that the system remediate all chemical and biological contaminants from the air. Therefore, the LifeAire System was engineered to kill the anthrax spore, the most difficult biological to kill.

    Because of its effectiveness towards the anthrax spore, the LifeAire System is able to remediate airborne pathogens such as clostridium difficile, MRSA, aspergillus, influenza, TB, streptococcus, COVID-19, etc., each representing a consistent threat to both the hospital environment and hospital acquired infection (HAI) rate.

    Contact us to learn more about our transformational technology and how it can help your organization.

    Go to Top